Function of AP-1 in Transcription of the Telomerase Reverse Transcriptase Gene (TERT) in Human and Mouse Cells

ABSTRACT The transcriptional regulation of the human telomerase catalytic subunit (hTERT) plays a critical role in telomerase activity. Approximately 200 bp of the proximal core promoter is responsible for basic hTERT expression; however, the function of the distal regulatory elements remains unclear. The transcription factor activator protein 1 (AP-1) is involved in cellular proliferation, differentiation, carcinogenesis, and apoptosis and is expressed broadly in both cancer and normal cells. There are several putative AP-1 sites in the hTERT promoter, but their functions are unknown. The present study examined the regulatory role of AP-1 in hTERT gene transcription. Overexpression of AP-1 leads to transcriptional suppression of hTERT in cancer cells. The combination of c-Fos and c-Jun or c-Fos and JunD strongly suppresses hTERT promoter activity in transient-expression analyses. The hTERT promoter region between −2000 and −378 is responsible for this function. Gel shift and supershift analyses, as well as ChIP, show binding of JunD and c-Jun on two putative AP-1 sites within this region. Mutations in the AP-1 binding sites rescued suppressions caused by AP-1, suggesting this is a direct regulation of the hTERT promoter. In contrast, there was no effect on mTERT expression or mTERT promoter activity by AP-1 overexpression in mouse fibroblasts. The species-specific function of AP-1 in TERT expression may in part help explain the difference in telomerase activity between normal human and mouse cells.

[1]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[2]  Z. Ronai,et al.  c-Jun-NH2 Kinase (JNK) Contributes to the Regulation of c-Myc Protein Stability* , 2004, Journal of Biological Chemistry.

[3]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[4]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[5]  M. Oshimura,et al.  Functional evidence for a telomerase repressor gene on human chromosome 10p15.1 , 2001, Oncogene.

[6]  June Corwin,et al.  Telomerase Catalytic Subunit Homologs from Fission Yeast and Human , 1997 .

[7]  M. Yutsudo,et al.  Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). , 2000, Nucleic acids research.

[8]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[9]  J. Shay,et al.  Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. , 1995, Journal of immunology.

[10]  F. Ishikawa,et al.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas , 1998, Nature Genetics.

[11]  S. Kyo,et al.  Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues , 1999, International journal of cancer.

[12]  T. Ide,et al.  Telomerase activity in normal human epithelial cells. , 1996, Oncogene.

[13]  F. Ishikawa,et al.  Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development. , 2001, Carcinogenesis.

[14]  S. Kyo,et al.  Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. , 1998, Cancer research.

[15]  S. Kyo,et al.  hTERT is a critical determinant of telomerase activity in renal‐cell carcinoma , 1998, International journal of cancer.

[16]  M. Yutsudo,et al.  Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. , 1999, Cancer research.

[17]  J. Shay,et al.  Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. , 2001, Nucleic acids research.

[18]  S. Kyo,et al.  Telomerase activity in human endometrium. , 1997, Cancer research.

[19]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[20]  M. Oshimura,et al.  Human chromosome 5 carries a putative telomerase repressor gene , 2003, Genes, chromosomes & cancer.

[21]  J. Barrett,et al.  Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. , 1999, Cancer research.

[22]  Y. Cong,et al.  The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. , 1999, Human molecular genetics.

[23]  P. Boukamp,et al.  Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Huan Yang,et al.  Telomerase is regulated by c-Jun NH2-terminal kinase in ovarian surface epithelial cells. , 2002, Cancer research.

[25]  J. Weitzman,et al.  A role for AP-1 in apoptosis: the case for and against. , 2003, Biochimie.

[26]  S. Kyo,et al.  Telomerase activation by histone deacetylase inhibitor in normal cells. , 2001, Nucleic acids research.

[27]  C B Harley,et al.  Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Karin,et al.  Activation of cAMP and mitogen responsive genes relies on a common nuclear factor , 1994, Nature.

[29]  B. Leber,et al.  Telomerase activity in normal leukocytes and in hematologic malignancies. , 1995, Blood.

[30]  K. Isobe,et al.  Mechanism for the Reduction of Telomerase Expression during Muscle Cell Differentiation* , 2001, The Journal of Biological Chemistry.

[31]  S. Kyo,et al.  Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  M. Yaniv,et al.  Both Jun and Fos contribute to transcription activation by the heterodimer. , 1990, Oncogene.

[33]  M. Acunzo,et al.  The Platelet-derived Growth Factor Controls c-myc Expression through a JNK- and AP-1-dependent Signaling Pathway* , 2003, Journal of Biological Chemistry.

[34]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[35]  J. Barrett,et al.  DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. , 1999, Cancer research.

[36]  P. Bushel,et al.  Two serum response elements mediate transcriptional repression of human smooth muscle alpha-actin promoter in ras-transformed cells. , 1995, Oncogene.

[37]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[38]  L. Chin,et al.  Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation , 1998, Oncogene.

[39]  M. Oshimura,et al.  Evidence for a putative telomerase repressor gene in the 3p14.2–p21.1 region , 1998, Genes, chromosomes & cancer.

[40]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[41]  C. Autexier,et al.  Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA. , 1996, The EMBO journal.

[42]  S. Kyo,et al.  Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy? , 2002, Oncogene.

[43]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[44]  E. Wagner,et al.  Control of cell cycle progression by c-Jun is p53 dependent. , 1999, Genes & development.